Next, in PAN02 bilateral subcutaneous tumor models, GN + OBP-702 significantly suppressed the growth of not only OBP-702-injected tumors, but also OBP-702-uninjected tumors (Fig. 4a), and this anti-tumor activity on uninjected tumors was significantly reduced by anti-CD8α injection (Fig. 4b and Supplementary Fig. S6a–c). Here, CD8A is linked to neoplasm.